BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2437001)

  • 41. [Human monoclonal antibody constructed by lymphocytes from pancreatic cancer patients].
    Tanaka H
    Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):93-101. PubMed ID: 2539553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel tumor-associated antigen of hepatocellular carcinoma defined by monoclonal antibody E4-65.
    Zou K; Ju J; Xie H
    Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):359-65. PubMed ID: 17492133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunological screening of a glycoprotein antigen expressed by Zajdela ascites hepatoma cells on normal rat tissues and tumour cells.
    Nato F; Goulut C; Mirshahi M; Bourrillon R
    Scand J Immunol; 1991 Oct; 34(4):411-9. PubMed ID: 1656518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Preliminary studies of apoptotic cell-associated antigens on hepatoma].
    Ma Y; Wang W
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):22-4. PubMed ID: 10921049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-surface changes associated with transformation of human hepatocytes to the malignant phenotype.
    Wilson B; Ozturk M; Takahashi H; Motté P; Kew M; Isselbacher KJ; Wands JR
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3140-4. PubMed ID: 2834734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Two mouse hybridomas secreting monoclonal antibodies against human liver carcinoma and their antibody specificity].
    Xie H; Yang ZH; Chen RM; Yao Z; Wang BM; Guo SY; Yan ZF
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):263-70. PubMed ID: 2424200
    [No Abstract]   [Full Text] [Related]  

  • 47. Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.
    Shouval D; Adler R; Wands JR; Hurwitz E; Isselbacher KJ; Sela M
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8276-80. PubMed ID: 2460865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for possible emergence of immunochemically distinct nucleotide-peptides in malignant transformation.
    Islam MN
    Experientia; 1978 Feb; 34(2):254-5. PubMed ID: 203477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
    Yamashita Y; Koike K; Takaoki M; Matsuda S
    Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal antibody against human gallbladder carcinoma-associated antigen.
    Koyama S; Mukai R; Fukao K; Arimura H; Iwasaki Y; Osuga T
    Cancer Res; 1987 Sep; 47(17):4667-73. PubMed ID: 3304618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma.
    Takahashi H; Ozturk M; Wilson B; Maki A; Ozawa K; Koizumi M; Endo K; Strauss W; Shouval D; Wands J
    Hepatology; 1989 Apr; 9(4):625-34. PubMed ID: 2538386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo detection of human hepatoma secreting hepatitis B surface antigen in nude mice with radiolabeled monoclonal antibodies that recognize distinct epitopes.
    Henkel RD; Kennedy RC; Sparrow JT; Dreesman GR
    Clin Immunol Immunopathol; 1985 May; 35(2):146-55. PubMed ID: 2416499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purification of HBsAg produced by the human hepatoma cell line PLC/PRE/5 by affinity chromatography using monoclonal antibodies and application for ELISA diagnostic.
    Merten OW; Reiter S; Scheirer W; Katinger H
    Dev Biol Stand; 1983; 55():121-7. PubMed ID: 6329855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression of human hepatoma associated antigen in relation to the cell cycle].
    Zhu XY
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):322-4. PubMed ID: 1664314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hepatitis B virus and hepatoma: evidence for a cytoplasmic tumor antigen in transformed hepatocytes].
    Romet-Lemonne JL; Barin F; Goudeau A; Maupas P
    C R Seances Acad Sci III; 1982 Jan; 294(1):9-14. PubMed ID: 6280812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
    Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
    Ng LT; Chiang LC; Lin YT; Lin CC
    Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Localization of hepatocellular carcinoma with monoclonal antibodies].
    Liu Y
    Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):362-5, 26. PubMed ID: 1659475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.
    Yang LJ; Wang WL
    World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.